G. Benninger-doring et al., Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers, VIROLOGY, 264(2), 1999, pp. 289-297
We investigated CD8(+) T cell frequencies of five different Epstein-Barr vi
rus-specific cytotoxic T lymphocyte epitopes located within proteins of the
replicative cycle and the latent state in healthy long-term Virus carriers
with IFN-gamma enzyme-linked immunospot assay. Frequencies of the HLA-A3-r
estricted epitope RVRAYTYSK (RVR) whose minimal length was mapped in this s
tudy to amino acid position 148-156 of the immediate-early protein BRLF1 we
re compared with those of a further known HLA-A3-restricted epitope within
EBNA3A, RLRAEAQVK (RLR). Determination of frequencies of CD8(+) T lymphocyt
es directed against lytic antigen epitope RVR revealed that only one of eig
ht donors recognized this epitope. Frequency was calculated to be 65 RVR-sp
ecific CD8(+) T lymphocytes per 10(6) PBMC. None of the HLA-A3-positive don
ors exhibited IFN-gamma release after antigenic stimulation with the EBNA3A
-specific peptide epitope RLR. Furthermore, we chose three known HLA-B8-res
tricted epitopes, RAKFKQLL (RAK), FLRGRAYGL (FLR), and QAKWRLQTL (QAK), of
the lytic protein BZLF1 and the latent protein EBNA3A. Examination of eight
HLA-BB-positive virus carriers revealed that the BZLF1-specific epitope RA
K was recognized by all donors with a median frequency of 233 RAK-specific
CD8(+) T lymphocytes per 10(6) PBMC. Only 50% of these donors reacted again
st EBNA3A-specific epitope FLR and a minority (25%) reacted against EBNA3A-
specific epitope QAK. (C) 1999 Academic Press.